Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Non-pharmacological Therapy
1.2.3 Pharmacological Therapy
1.3 Market by Application
1.3.1 Global Insomnia Therapy Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Insomnia Therapy Market Perspective (2018-2033)
2.2 Insomnia Therapy Growth Trends by Region
2.2.1 Global Insomnia Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Insomnia Therapy Historic Market Size by Region (2018-2023)
2.2.3 Insomnia Therapy Forecasted Market Size by Region (2024-2033)
2.3 Insomnia Therapy Market Dynamics
2.3.1 Insomnia Therapy Industry Trends
2.3.2 Insomnia Therapy Market Drivers
2.3.3 Insomnia Therapy Market Challenges
2.3.4 Insomnia Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Insomnia Therapy Players by Revenue
3.1.1 Global Top Insomnia Therapy Players by Revenue (2018-2023)
3.1.2 Global Insomnia Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Insomnia Therapy Revenue
3.4 Global Insomnia Therapy Market Concentration Ratio
3.4.1 Global Insomnia Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Therapy Revenue in 2022
3.5 Insomnia Therapy Key Players Head office and Area Served
3.6 Key Players Insomnia Therapy Product Solution and Service
3.7 Date of Enter into Insomnia Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Therapy Breakdown Data by Type
4.1 Global Insomnia Therapy Historic Market Size by Type (2018-2023)
4.2 Global Insomnia Therapy Forecasted Market Size by Type (2024-2033)
5 Insomnia Therapy Breakdown Data by Application
5.1 Global Insomnia Therapy Historic Market Size by Application (2018-2023)
5.2 Global Insomnia Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Insomnia Therapy Market Size (2018-2033)
6.2 North America Insomnia Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Insomnia Therapy Market Size by Country (2018-2023)
6.4 North America Insomnia Therapy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Insomnia Therapy Market Size (2018-2033)
7.2 Europe Insomnia Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Insomnia Therapy Market Size by Country (2018-2023)
7.4 Europe Insomnia Therapy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Therapy Market Size (2018-2033)
8.2 Asia-Pacific Insomnia Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Insomnia Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Insomnia Therapy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Insomnia Therapy Market Size (2018-2033)
9.2 Latin America Insomnia Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Insomnia Therapy Market Size by Country (2018-2023)
9.4 Latin America Insomnia Therapy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Therapy Market Size (2018-2033)
10.2 Middle East & Africa Insomnia Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Insomnia Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Insomnia Therapy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck & Co.
11.1.1 Merck & Co. Company Detail
11.1.2 Merck & Co. Business Overview
11.1.3 Merck & Co. Insomnia Therapy Introduction
11.1.4 Merck & Co. Revenue in Insomnia Therapy Business (2018-2023)
11.1.5 Merck & Co. Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Insomnia Therapy Introduction
11.2.4 Sanofi Revenue in Insomnia Therapy Business (2018-2023)
11.2.5 Sanofi Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Insomnia Therapy Introduction
11.3.4 Pfizer Revenue in Insomnia Therapy Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Takeda Pharmaceutical Company Ltd.
11.4.1 Takeda Pharmaceutical Company Ltd. Company Detail
11.4.2 Takeda Pharmaceutical Company Ltd. Business Overview
11.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Introduction
11.4.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2018-2023)
11.4.5 Takeda Pharmaceutical Company Ltd. Recent Development
11.5 Purdue Pharmaceuticals L.P.
11.5.1 Purdue Pharmaceuticals L.P. Company Detail
11.5.2 Purdue Pharmaceuticals L.P. Business Overview
11.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Introduction
11.5.4 Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2018-2023)
11.5.5 Purdue Pharmaceuticals L.P. Recent Development
11.6 Eisai, Co. Ltd.
11.6.1 Eisai, Co. Ltd. Company Detail
11.6.2 Eisai, Co. Ltd. Business Overview
11.6.3 Eisai, Co. Ltd. Insomnia Therapy Introduction
11.6.4 Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2018-2023)
11.6.5 Eisai, Co. Ltd. Recent Development
11.7 Meda Consumer Healthcare
11.7.1 Meda Consumer Healthcare Company Detail
11.7.2 Meda Consumer Healthcare Business Overview
11.7.3 Meda Consumer Healthcare Insomnia Therapy Introduction
11.7.4 Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2018-2023)
11.7.5 Meda Consumer Healthcare Recent Development
11.8 Pernix Therapeutics
11.8.1 Pernix Therapeutics Company Detail
11.8.2 Pernix Therapeutics Business Overview
11.8.3 Pernix Therapeutics Insomnia Therapy Introduction
11.8.4 Pernix Therapeutics Revenue in Insomnia Therapy Business (2018-2023)
11.8.5 Pernix Therapeutics Recent Development
11.9 Vanda Pharmaceuticals
11.9.1 Vanda Pharmaceuticals Company Detail
11.9.2 Vanda Pharmaceuticals Business Overview
11.9.3 Vanda Pharmaceuticals Insomnia Therapy Introduction
11.9.4 Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2018-2023)
11.9.5 Vanda Pharmaceuticals Recent Development
11.10 ECR Pharmaceuticals
11.10.1 ECR Pharmaceuticals Company Detail
11.10.2 ECR Pharmaceuticals Business Overview
11.10.3 ECR Pharmaceuticals Insomnia Therapy Introduction
11.10.4 ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2018-2023)
11.10.5 ECR Pharmaceuticals Recent Development
11.11 Fidia Farmaceutici
11.11.1 Fidia Farmaceutici Company Detail
11.11.2 Fidia Farmaceutici Business Overview
11.11.3 Fidia Farmaceutici Insomnia Therapy Introduction
11.11.4 Fidia Farmaceutici Revenue in Insomnia Therapy Business (2018-2023)
11.11.5 Fidia Farmaceutici Recent Development
11.12 Dainippon Sumitomo
11.12.1 Dainippon Sumitomo Company Detail
11.12.2 Dainippon Sumitomo Business Overview
11.12.3 Dainippon Sumitomo Insomnia Therapy Introduction
11.12.4 Dainippon Sumitomo Revenue in Insomnia Therapy Business (2018-2023)
11.12.5 Dainippon Sumitomo Recent Development
11.13 Biocodex
11.13.1 Biocodex Company Detail
11.13.2 Biocodex Business Overview
11.13.3 Biocodex Insomnia Therapy Introduction
11.13.4 Biocodex Revenue in Insomnia Therapy Business (2018-2023)
11.13.5 Biocodex Recent Development
11.14 Eli Lilly and Company
11.14.1 Eli Lilly and Company Company Detail
11.14.2 Eli Lilly and Company Business Overview
11.14.3 Eli Lilly and Company Insomnia Therapy Introduction
11.14.4 Eli Lilly and Company Revenue in Insomnia Therapy Business (2018-2023)
11.14.5 Eli Lilly and Company Recent Development
11.15 Ebb Therapeutics
11.15.1 Ebb Therapeutics Company Detail
11.15.2 Ebb Therapeutics Business Overview
11.15.3 Ebb Therapeutics Insomnia Therapy Introduction
11.15.4 Ebb Therapeutics Revenue in Insomnia Therapy Business (2018-2023)
11.15.5 Ebb Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Insomnia Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Non-pharmacological Therapy
Table 3. Key Players of Pharmacological Therapy
Table 4. Global Insomnia Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Insomnia Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Insomnia Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Insomnia Therapy Market Share by Region (2018-2023)
Table 8. Global Insomnia Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Insomnia Therapy Market Share by Region (2024-2033)
Table 10. Insomnia Therapy Market Trends
Table 11. Insomnia Therapy Market Drivers
Table 12. Insomnia Therapy Market Challenges
Table 13. Insomnia Therapy Market Restraints
Table 14. Global Insomnia Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Insomnia Therapy Market Share by Players (2018-2023)
Table 16. Global Top Insomnia Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapy as of 2022)
Table 17. Ranking of Global Top Insomnia Therapy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Insomnia Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Insomnia Therapy Product Solution and Service
Table 21. Date of Enter into Insomnia Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Insomnia Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Insomnia Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global Insomnia Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Insomnia Therapy Revenue Market Share by Type (2024-2033)
Table 27. Global Insomnia Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Insomnia Therapy Revenue Market Share by Application (2018-2023)
Table 29. Global Insomnia Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Insomnia Therapy Revenue Market Share by Application (2024-2033)
Table 31. North America Insomnia Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Insomnia Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Insomnia Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Insomnia Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Insomnia Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Insomnia Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Insomnia Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Insomnia Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Insomnia Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Insomnia Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Insomnia Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Insomnia Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Insomnia Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Insomnia Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Insomnia Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 46. Merck & Co. Company Detail
Table 47. Merck & Co. Business Overview
Table 48. Merck & Co. Insomnia Therapy Product
Table 49. Merck & Co. Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 50. Merck & Co. Recent Development
Table 51. Sanofi Company Detail
Table 52. Sanofi Business Overview
Table 53. Sanofi Insomnia Therapy Product
Table 54. Sanofi Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 55. Sanofi Recent Development
Table 56. Pfizer Company Detail
Table 57. Pfizer Business Overview
Table 58. Pfizer Insomnia Therapy Product
Table 59. Pfizer Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. Takeda Pharmaceutical Company Ltd. Company Detail
Table 62. Takeda Pharmaceutical Company Ltd. Business Overview
Table 63. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product
Table 64. Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 65. Takeda Pharmaceutical Company Ltd. Recent Development
Table 66. Purdue Pharmaceuticals L.P. Company Detail
Table 67. Purdue Pharmaceuticals L.P. Business Overview
Table 68. Purdue Pharmaceuticals L.P. Insomnia Therapy Product
Table 69. Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 70. Purdue Pharmaceuticals L.P. Recent Development
Table 71. Eisai, Co. Ltd. Company Detail
Table 72. Eisai, Co. Ltd. Business Overview
Table 73. Eisai, Co. Ltd. Insomnia Therapy Product
Table 74. Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 75. Eisai, Co. Ltd. Recent Development
Table 76. Meda Consumer Healthcare Company Detail
Table 77. Meda Consumer Healthcare Business Overview
Table 78. Meda Consumer Healthcare Insomnia Therapy Product
Table 79. Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 80. Meda Consumer Healthcare Recent Development
Table 81. Pernix Therapeutics Company Detail
Table 82. Pernix Therapeutics Business Overview
Table 83. Pernix Therapeutics Insomnia Therapy Product
Table 84. Pernix Therapeutics Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 85. Pernix Therapeutics Recent Development
Table 86. Vanda Pharmaceuticals Company Detail
Table 87. Vanda Pharmaceuticals Business Overview
Table 88. Vanda Pharmaceuticals Insomnia Therapy Product
Table 89. Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 90. Vanda Pharmaceuticals Recent Development
Table 91. ECR Pharmaceuticals Company Detail
Table 92. ECR Pharmaceuticals Business Overview
Table 93. ECR Pharmaceuticals Insomnia Therapy Product
Table 94. ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 95. ECR Pharmaceuticals Recent Development
Table 96. Fidia Farmaceutici Company Detail
Table 97. Fidia Farmaceutici Business Overview
Table 98. Fidia Farmaceutici Insomnia Therapy Product
Table 99. Fidia Farmaceutici Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 100. Fidia Farmaceutici Recent Development
Table 101. Dainippon Sumitomo Company Detail
Table 102. Dainippon Sumitomo Business Overview
Table 103. Dainippon Sumitomo Insomnia Therapy Product
Table 104. Dainippon Sumitomo Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 105. Dainippon Sumitomo Recent Development
Table 106. Biocodex Company Detail
Table 107. Biocodex Business Overview
Table 108. Biocodex Insomnia Therapy Product
Table 109. Biocodex Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 110. Biocodex Recent Development
Table 111. Eli Lilly and Company Company Detail
Table 112. Eli Lilly and Company Business Overview
Table 113. Eli Lilly and Company Insomnia Therapy Product
Table 114. Eli Lilly and Company Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 115. Eli Lilly and Company Recent Development
Table 116. Ebb Therapeutics Company Detail
Table 117. Ebb Therapeutics Business Overview
Table 118. Ebb Therapeutics Insomnia Therapy Product
Table 119. Ebb Therapeutics Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 120. Ebb Therapeutics Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Insomnia Therapy Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Insomnia Therapy Market Share by Type: 2022 VS 2033
Figure 3. Non-pharmacological Therapy Features
Figure 4. Pharmacological Therapy Features
Figure 5. Global Insomnia Therapy Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Insomnia Therapy Market Share by Application: 2022 VS 2033
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Insomnia Therapy Report Years Considered
Figure 11. Global Insomnia Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Insomnia Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Insomnia Therapy Market Share by Region: 2022 VS 2033
Figure 14. Global Insomnia Therapy Market Share by Players in 2022
Figure 15. Global Top Insomnia Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Insomnia Therapy Revenue in 2022
Figure 17. North America Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Insomnia Therapy Market Share by Country (2018-2033)
Figure 19. United States Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Insomnia Therapy Market Share by Country (2018-2033)
Figure 23. Germany Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Insomnia Therapy Market Share by Region (2018-2033)
Figure 31. China Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Insomnia Therapy Market Share by Country (2018-2033)
Figure 39. Mexico Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Insomnia Therapy Market Share by Country (2018-2033)
Figure 43. Turkey Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Merck & Co. Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 46. Sanofi Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 47. Pfizer Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 48. Takeda Pharmaceutical Company Ltd. Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 49. Purdue Pharmaceuticals L.P. Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 50. Eisai, Co. Ltd. Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 51. Meda Consumer Healthcare Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 52. Pernix Therapeutics Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 53. Vanda Pharmaceuticals Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 54. ECR Pharmaceuticals Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 55. Fidia Farmaceutici Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 56. Dainippon Sumitomo Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 57. Biocodex Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 58. Eli Lilly and Company Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 59. Ebb Therapeutics Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed